Corcept Therapeutics Incorporated (LON:0I3Q)
London
· Delayed Price · Currency is GBP · Price in USD 73.66
+2.64 (3.71%)
Apr 28, 2025, 5:15 PM BST
Corcept Therapeutics Market Cap
Corcept Therapeutics has a market cap or net worth of 5.59 billion as of April 29, 2025. Its market cap has increased by 182.85% in one year.
Market Cap
5.59B
Enterprise Value
5.15B
Revenue
539.20M
Ranking
n/a
PE Ratio
50.09
Stock Price
73.66
Market Cap Chart
Since April 14, 2004, Corcept Therapeutics's market cap has increased from 154.68M to 5.59B, an increase of 3,514.49%. That is a compound annual growth rate of 18.58%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 161.27B |
| GSK plc | 56.28B |
| Haleon | 34.06B |
| Smith & Nephew | 8.68B |
| ConvaTec Group | 5.25B |
| Hikma Pharmaceuticals | 4.19B |
| HUTCHMED (China) | 1.95B |
| Oxford Nanopore Technologies | 1.14B |